Index
Module 8 • Clinical Pharmacology
Pharmacokinetics/Pharmacodynamics
10%
Data Tables
Pharmacokinetics/Pharmacodynamics
Joseph M. Swanson ~3 min read Module 8 of 20
4
/ 39

Pharmacokinetics/Pharmacodynamics

subcutaneously every 12 hours, and fosphenytoin 150 mg

intravenously every 8 hours.

2Which most accurately assesses the risk factors for

the decreased absorption of enterally administered

drugs?

A.Intestinal

atrophy,

pantoprazole

therapy,

abdominal surgery.

B.TBI, fentanyl therapy, cardiac output.
C.Abdominal surgery, pantoprazole therapy, TBI.
D.Intestinal atrophy, cardiac output, fentanyl

therapy.

3

Before E.W.’s ICU admission, his albumin concen-

tration was 3.8 g/dL, but after surgery, it decreased

to 2.1 g/dL. Given this change in albumin, which

change in the total and unbound concentration of

propofol would be most likely?

A.Increased

total

concentration,

decreased

unbound concentration.

B.No change in total concentration, increased

unbound concentration.

C.Increased total concentration, no change in

unbound concentration.

D.Decreased

total

concentration,

increased

unbound concentration.

4

On postoperative day 3, E.W.’s SCr increased to 3

mg/dL. On postoperative day 4, his SCr is 3.2 mg/

dL. Which variable for assessing kidney function

would be most important for determining E.W.’s

dosing adjustments?

A.BUN/SCr ratio.
B.Total daily urinary output.
C.Estimation of glomerular filtration rate (GFR).
D.History of chronic kidney disease (CKD).

Questions 5 and 6 pertain to the following case.

S.H. is a 35-year-old man (height 70 inches, weight

85 kg) admitted to the medical ICU because of sepsis

caused by hospital-acquired pneumonia. He is empiri-

cally treated with intermittent vancomycin, piperacillin/

tazobactam, and ciprofloxacin. His laboratory values

are as follows: SCr 1 mg/dL, BUN 12 mg/dL, and WBC

18 × 103 cells/mm3.

5

According to S.H.’s anticipated PK changes and

guideline recommendations, which would be the

most appropriate intravenous loading dose of

vancomycin?

A.1000 mg.
B.1500 mg.
C.2500 mg.
D.3500 mg.
6

S.H. is given a diagnosis of methicillin-resistant

Staphylococcus aureus hospital-acquired pneu-

monia. On day 10 of vancomycin therapy, his

vancomycin area under the curve (AUC) is 700 mg

x h/L. His previous vancomycin AUC was 425 mg x

h/L on the same dosing regimen. Which most likely

explains what transpired?

A.Augmented renal excretion returned to normal.
B.Vd increased to larger than normal.
C.Tissue penetration decreased to below normal.
D.Liver blood flow returned to normal.
7

B.B. is 40-year-old woman with a surgical site

infection caused by Pseudomonas aeruginosa.

She is initiated on a piperacillin/tazobactam 3.375

g intravenous infusion over 4 hours every 8 hours.

Which is the most likely benefit of this approach

with piperacillin/tazobactam?

A.Decreased mortality supported by prospective

controlled studies.

B.Decreased neurotoxicity supported by prospec-

tive controlled studies.

C.Decreased mortality supported by retrospective

reviews.

D.Decreased neurotoxicity supported by retro-

spective reviews.

8

C.W. is a 52-year-old man admitted to the ICU for

acute respiratory failure. He is given scheduled

oral morphine for pain control. Which PK variable

would most likely affect the hepatic metabolism of

morphine?

A.Increased α1-acid glycoprotein (AAG).
B.Decreased albumin.
C.Increased hepatic blood flow.
D.Increased intrinsic clearance.
HD Video Explanation — Synchronized with PDF
Starts at: minute 3 Open on YouTube